RCE just published their Phase I Data Review ,, A comprehensive overview of their Phase I Clinical Trials,,, up 11c ,, Easy To Read , full of Valuable Factual Information, clear and concise , simple Graphs and Charts...
This is exactly what PAA is absolutely Lacking ,,, I invite you all to read it and see how a Biotech Delivers Data...Tell me I'm wrong
https://stocknessmonster.com/announcements/rce.asx-6A1158991/
That's how you get the Oppies in the money NZT
Ann: Results show MPL suppresses biomarkers associated with MND, page-201
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $86.55M | |||
| Open | High | Low | Value | Volume |
| 19.5¢ | 19.5¢ | 18.5¢ | $330.4K | 1.741M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 4071 | 19.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 19.5¢ | 24580 | 3 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| PAA (ASX) Chart |